However, in PRAD, HNSC, KIRC, BRCA, KIPA, skin cutaneous melanoma (SKCM), bladder urothelial carcinoma (BLCA), and adenoid cystic carcinoma (ACC), GPX3 expression was lower in the higher T stage (Figure 2B). The gene discussed is GPX3; the disease is prostate adenocarcinoma.